Objective: The aim of this study was to examine the effects of an intensive, multidisciplinary, inpatient rehabilitation program on the functional outcomes of patients with Parkinson's disease (PD), ...
AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an advance in its ...
MindWalk Holdings Corp. (NASDAQ:HYFT) (“MindWalk” or the “Company”), a Bio-Native AI therapeutic research and technology company, today announced an advance in its universal influenza program ...
Validated Across Influenza A and Influenza B, Including H3N2 Subclade K and Zoonotic Influenza A Subtypes H5, H7, H9 Using its patented HYFT® Deep Data technology, MindWalk identified a functional ...
New Phase I/II RGX-202 functional data demonstrates long-term, durable treatment effect at pivotal dose at 18 months Robust patient enrollment in confirmatory trial continues, expect majority of ...
ROCKVILLE, Md., Jan. 11, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) highlighted progress and upcoming anticipated milestones across its pipeline of AAV gene therapies for rare and retinal ...
Abstract: Many organizations rely on software systems to perform their core business operations. These systems often require modernization to accommodate new requirements and demands over time. Visual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results